Le Lézard
Classified in: Health
Subject: SVY

Global Healthcare IT Market 2018-2022 - Emergence of AI-Enabled Emotion Recognition Technologies


DUBLIN, Sept 21, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Global Healthcare IT Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The analysts forecast the global healthcare IT market to grow at a CAGR of 8.4% during the period 2018-2022.

Global Healthcare IT Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. To calculate the market size, the report considers the revenue generated from the use of healthcare IT market in different components.

The latest trend gaining momentum in the market is the emergence of AI-enabled emotion recognition technologies. The AI algorithm analyzes the expressions and provides an accurate analysis of the patients in real time. This helps in arriving at an accurate diagnosis and ensuring correct treatment.

According to the report, one of the major drivers for this market is the increasing need to improve efficiency and reduce costs. Investing in IT hardware and software tools has reduced the workload for doctors and support staff which has helped to improve the quality of treatment.

Further, the report states that one of the major factors hindering the growth of this market is the vulnerability of EMR toward cybercrime. The easy accessibility of data makes it susceptible to being hacked, modified, or misused. This is proving to be a significant threat to the growth of the global IT healthcare market.


Key vendors

Key Topics Covered:

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

PART 05: MARKET SIZING 2017-2022

PART 06: FIVE FORCES ANALYSIS
PART 07: MARKET SEGMENTATION BY COMPONENT

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

PART 12: MARKET TRENDS

PART 13: VENDOR LANDSCAPE

PART 14: VENDOR ANALYSIS

For more information about this report visit

https://www.researchandmarkets.com/research/ssm4cg/global_healthcare?w=5

Did you know that we also offer Custom Research? Visit our Custom Research page to learn more and schedule a meeting with our Custom Research Manager.

Media Contact:


Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 

SOURCE Research and Markets


These press releases may also interest you

at 18:50
Getting specialty medications into...

at 18:30
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

at 18:23
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

at 17:55
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

at 17:20
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...

at 17:00
StateHouse Holdings Inc. ("StateHouse" or the "Company") , a California-focused, vertically integrated cannabis company, today announced further to its press release dated April 15, 2024, that the Ontario Securities Commission (the "OSC") has denied...



News published on and distributed by: